176 related articles for article (PubMed ID: 20979799)
41. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
Travers J; Laveneziana P; Webb KA; Kesten S; O'Donnell DE
Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
[TBL] [Abstract][Full Text] [Related]
42. Improvements with tiotropium in COPD patients with concomitant asthma.
Magnussen H; Bugnas B; van Noord J; Schmidt P; Gerken F; Kesten S
Respir Med; 2008 Jan; 102(1):50-6. PubMed ID: 17920256
[TBL] [Abstract][Full Text] [Related]
43. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
[TBL] [Abstract][Full Text] [Related]
44. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.
Joos GF; Brusselle G; Derom E; Pauwels R
Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894
[TBL] [Abstract][Full Text] [Related]
45. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan.
Hsu JY; Perng RP; Lu JY; Wu CP; Huang MS; Luh KT; Yang PC
J Formos Med Assoc; 2006 Sep; 105(9):708-14. PubMed ID: 16959618
[TBL] [Abstract][Full Text] [Related]
46. The effect of tiotropium on exacerbations and airflow in patients with COPD.
Dusser D; Bravo ML; Iacono P
Eur Respir J; 2006 Mar; 27(3):547-55. PubMed ID: 16507855
[TBL] [Abstract][Full Text] [Related]
47. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.
Casaburi R; Mahler DA; Jones PW; Wanner A; San PG; ZuWallack RL; Menjoge SS; Serby CW; Witek T
Eur Respir J; 2002 Feb; 19(2):217-24. PubMed ID: 11866001
[TBL] [Abstract][Full Text] [Related]
48. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease].
Ma J; Zhou Z; Tang Y; Zhong N
Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564
[TBL] [Abstract][Full Text] [Related]
49. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.
Donohue JF; van Noord JA; Bateman ED; Langley SJ; Lee A; Witek TJ; Kesten S; Towse L
Chest; 2002 Jul; 122(1):47-55. PubMed ID: 12114338
[TBL] [Abstract][Full Text] [Related]
50. Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.
Cole JM; Sheehan AH; Jordan JK
Ann Pharmacother; 2012 Dec; 46(12):1717-21. PubMed ID: 23170031
[TBL] [Abstract][Full Text] [Related]
51. Tiotropium improves walking endurance in COPD.
Bédard ME; Brouillard C; Pepin V; Provencher S; Milot J; Lacasse Y; Leblanc P; Maltais F
Eur Respir J; 2012 Feb; 39(2):265-71. PubMed ID: 21700602
[TBL] [Abstract][Full Text] [Related]
52. Bronchodilator responsiveness in patients with COPD.
Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S
Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071
[TBL] [Abstract][Full Text] [Related]
53. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
[TBL] [Abstract][Full Text] [Related]
54. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
[TBL] [Abstract][Full Text] [Related]
55. Tiotropium Respimat inhaler and the risk of death in COPD.
Wise RA; Anzueto A; Cotton D; Dahl R; Devins T; Disse B; Dusser D; Joseph E; Kattenbeck S; Koenen-Bergmann M; Pledger G; Calverley P;
N Engl J Med; 2013 Oct; 369(16):1491-501. PubMed ID: 23992515
[TBL] [Abstract][Full Text] [Related]
56. A one-year trial of tiotropium Respimat plus usual therapy in COPD patients.
Bateman ED; Tashkin D; Siafakas N; Dahl R; Towse L; Massey D; Pavia D; Zhong NS
Respir Med; 2010 Oct; 104(10):1460-72. PubMed ID: 20620037
[TBL] [Abstract][Full Text] [Related]
57. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
Celli B; ZuWallack R; Wang S; Kesten S
Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
[TBL] [Abstract][Full Text] [Related]
58. [Early treatment of COPD with tiotropium].
Buhl R; Welte T; Vogelmeier C; Gillissen A; Voshaar T; Kögler H; Liu D; Glaab T
Pneumologie; 2012 Oct; 66(10):589-95. PubMed ID: 23011771
[TBL] [Abstract][Full Text] [Related]
59. A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium.
Anzueto A; Niewoehner DE; Leimer I; Rühmkorf F; Celli BR; Decramer M; Tashkin DP
Respir Med; 2013 Dec; 107(12):1912-22. PubMed ID: 23969305
[TBL] [Abstract][Full Text] [Related]
60. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.
Vincken W; van Noord JA; Greefhorst AP; Bantje TA; Kesten S; Korducki L; Cornelissen PJ;
Eur Respir J; 2002 Feb; 19(2):209-16. PubMed ID: 11871363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
